Works matching IS 13524585 AND DT 2022 AND VI 28 AND IP 6
Results: 20
Physical exercise in multiple sclerosis is not just a symptomatic therapy, it has a disease-modifying effect: Commentary.
- Published in:
- Multiple Sclerosis Journal, 2022, v. 28, n. 6, p. 863, doi. 10.1177/13524585211072702
- By:
- Publication type:
- Article
Response to "Frailty in multiple sclerosis: A closer look at the deficit accumulation framework".
- Published in:
- 2022
- By:
- Publication type:
- Letter
Physical exercise in multiple sclerosis is not just a symptomatic therapy, it has a disease-modifying effect: No.
- Published in:
- Multiple Sclerosis Journal, 2022, v. 28, n. 6, p. 861, doi. 10.1177/13524585211064968
- By:
- Publication type:
- Article
Absence of attack-independent neuroaxonal injury in MOG antibody-associated disease: Longitudinal assessment of serum neurofilament light chain.
- Published in:
- Multiple Sclerosis Journal, 2022, v. 28, n. 6, p. 993, doi. 10.1177/13524585211063756
- By:
- Publication type:
- Article
Physical exercise in multiple sclerosis is not just a symptomatic therapy: It has a disease-modifying effect—Yes.
- Published in:
- Multiple Sclerosis Journal, 2022, v. 28, n. 6, p. 859, doi. 10.1177/13524585211061651
- By:
- Publication type:
- Article
Frailty in multiple sclerosis: A closer look at the deficit accumulation framework.
- Published in:
- 2022
- By:
- Publication type:
- Letter
Brighter spotty lesions on spinal MRI help differentiate AQP4 antibody-positive NMOSD from MOGAD.
- Published in:
- Multiple Sclerosis Journal, 2022, v. 28, n. 6, p. 989, doi. 10.1177/13524585211060326
- By:
- Publication type:
- Article
Oral contraceptives do not modify the risk of a second attack and disability accrual in a prospective cohort of women with a clinically isolated syndrome and early multiple sclerosis.
- Published in:
- Multiple Sclerosis Journal, 2022, v. 28, n. 6, p. 950, doi. 10.1177/13524585211053001
- By:
- Publication type:
- Article
Prediction of multiple sclerosis outcomes when switching to ocrelizumab.
- Published in:
- Multiple Sclerosis Journal, 2022, v. 28, n. 6, p. 958, doi. 10.1177/13524585211049986
- By:
- Publication type:
- Article
Long-term efficacy and safety of inebilizumab in neuromyelitis optica spectrum disorder: Analysis of aquaporin-4–immunoglobulin G–seropositive participants taking inebilizumab for ⩾4 years in the N-MOmentum trial.
- Published in:
- Multiple Sclerosis Journal, 2022, v. 28, n. 6, p. 925, doi. 10.1177/13524585211047223
- By:
- Publication type:
- Article
Free From Falls education and exercise program for reducing falls in people with multiple sclerosis: A randomized controlled trial.
- Published in:
- Multiple Sclerosis Journal, 2022, v. 28, n. 6, p. 980, doi. 10.1177/13524585211046898
- By:
- Publication type:
- Article
Epilepsy as a predictor of disease progression in multiple sclerosis.
- Published in:
- Multiple Sclerosis Journal, 2022, v. 28, n. 6, p. 942, doi. 10.1177/13524585211046739
- By:
- Publication type:
- Article
Exploring CSF neurofilament light as a biomarker for MS in clinical practice; a retrospective registry-based study.
- Published in:
- Multiple Sclerosis Journal, 2022, v. 28, n. 6, p. 872, doi. 10.1177/13524585211039104
- By:
- Publication type:
- Article
The emerging role of artificial intelligence in multiple sclerosis imaging.
- Published in:
- Multiple Sclerosis Journal, 2022, v. 28, n. 6, p. 849, doi. 10.1177/1352458520966298
- By:
- Publication type:
- Article
Characterizing 1-year development of cervical cord atrophy across different MS phenotypes: A voxel-wise, multicentre analysis.
- Published in:
- Multiple Sclerosis Journal, 2022, v. 28, n. 6, p. 885, doi. 10.1177/13524585211045545
- By:
- Publication type:
- Article
Time to diagnosis in multiple sclerosis: Epidemiological data from the German Multiple Sclerosis Registry.
- Published in:
- Multiple Sclerosis Journal, 2022, v. 28, n. 6, p. 865, doi. 10.1177/13524585211039753
- By:
- Publication type:
- Article
Cognition and disease characteristics in adult onset versus late onset multiple sclerosis.
- Published in:
- Multiple Sclerosis Journal, 2022, v. 28, n. 6, p. 933, doi. 10.1177/13524585211039112
- By:
- Publication type:
- Article
Gray matter atrophy in relapsing-remitting multiple sclerosis is associated with white matter lesions in connecting fibers.
- Published in:
- Multiple Sclerosis Journal, 2022, v. 28, n. 6, p. 900, doi. 10.1177/13524585211044957
- By:
- Publication type:
- Article
Rapid and sustained B-cell depletion with subcutaneous ofatumumab in relapsing multiple sclerosis: APLIOS, a randomized phase-2 study.
- Published in:
- Multiple Sclerosis Journal, 2022, v. 28, n. 6, p. 910, doi. 10.1177/13524585211044479
- By:
- Publication type:
- Article
Risk factors for peripartum depression in women with multiple sclerosis.
- Published in:
- Multiple Sclerosis Journal, 2022, v. 28, n. 6, p. 970, doi. 10.1177/13524585211041108
- By:
- Publication type:
- Article